Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Yuichiro KANEKO"'
Autor:
Yoshiya Tanaka, Tsutomu Takeuchi, Hiroyuki Izutsu, Yuichiro Kaneko, Daisuke Kato, Musashi Fukuda, Mitsuhiro Rokuda, Neil M. Schultz
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-14 (2021)
Abstract Background Peficitinib (ASP015K), a novel oral Janus kinase inhibitor, has demonstrated efficacy and safety in the treatment of patients with rheumatoid arthritis (RA). This study evaluated the effect of peficitinib on patient- and physician
Externí odkaz:
https://doaj.org/article/0e383db5b7824d55930f43461ffee2ad
Autor:
Tsutomu Takeuchi, Yoshiya Tanaka, Jay Erdman, Yuichiro Kaneko, Masako Saito, Chieri Higashitani, Ronald Smulders, Christopher Lademacher
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Abstract Background Rheumatoid arthritis (RA) is a chronic, debilitating autoimmune condition characterized by joint synovial inflammation. Current treatments include methotrexate (MTX), biologic agents, and Janus kinase (JAK) inhibitors. However, th
Externí odkaz:
https://doaj.org/article/436bfbc159f642d981ede8a66257059d
Autor:
Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka, Atsushi Kawakami, Yeong-Wook Song, Yi-Hsing Chen, Mitsuhiro Rokuda, Hiroyuki Izutsu, Satoshi Ushijima, Yuichiro Kaneko, Yoshihiro Nakashima, Teruaki Shiomi, Emi Yamada
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-13 (2020)
Abstract Background Peficitinib (ASP015K), a novel oral Janus kinase inhibitor, has demonstrated efficacy and safety for the treatment of rheumatoid arthritis (RA) in randomized, controlled trials of up to 52 weeks’ duration. However, safety and ef
Externí odkaz:
https://doaj.org/article/8965f48d7e7a4015a93ac97744994b9f
Autor:
Junko Toyoshima, Atsunori Kaibara, Mai Shibata, Yuichiro Kaneko, Hiroyuki Izutsu, Tetsuya Nishimura
Publikováno v:
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)
Abstract The aim was to analyze the relationship between peficitinib exposure and efficacy response according to American College of Rheumatology (ACR) 20 criteria and 28‐joint disease activity score based on C‐reactive protein (DAS28‐CRP) in r
Externí odkaz:
https://doaj.org/article/fd008108937f4820a66711a6792b599c
Autor:
Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka, Atsushi Kawakami, Yeong-Wook Song, Yi-Hsing Chen, Mitsuhiro Rokuda, Hiroyuki Izutsu, Satoshi Ushijima, Yuichiro Kaneko, Yoshihiro Nakashima, Teruaki Shiomi, Emi Yamada
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-2 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/89af8f427d574a628004b16ceffc0493
Autor:
Yoshiya Tanaka, Tsutomu Takeuchi, Daisuke Kato, Yuichiro Kaneko, Musashi Fukuda, Hiroyuki Izutsu, Mitsuhiro Rokuda, Désirée van der Heijde
Publikováno v:
Modern Rheumatology. OXFORD UNIV PRESS
Modern Rheumatology
Modern Rheumatology
Objective To determine the efficacy of peficitinib in reducing joint damage and predictive factors affecting treatment response in Japanese patients with rheumatoid arthritis. Methods This post hoc analysis used data from a placebo-controlled, phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa28e02fa852982226b68ff0c6ede9b
https://doi.org/10.1093/mr/roac021
https://doi.org/10.1093/mr/roac021
Autor:
Ran Du, Shiqi Xie, Yuxin Fang, null PhD, Shinichi Hagino, Shinji Yamamoto, Muka Moriyama, Takeshi Yoshida, Tae Igarashi-Yokoi, Hiroyuki Takahashi, Natsuko Nagaoka, Kengo Uramoto, Yuka Onishi, Takashi Watanabe, Noriko Nakao, Tomonari Takahashi, Yuichiro Kaneko, Takeshi Azuma, Ryoma Hatake, Takuhei Nomura, Tatsuro Sakura, Mariko Yana, Jianping Xiong, Changyu Chen, Kyoko Ohno-Matsui
Publikováno v:
Asia-Pacific Journal of Ophthalmology. 11:227-236
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ad5024e025ba5659cad436732f99b0b
https://doi.org/10.1097/apo.0000000000000466
https://doi.org/10.1097/apo.0000000000000466
Autor:
Manish Patel, David Park, Stefano Tarantolo, Afshin Dowlati, Daniel Olson, Yuichiro Kaneko, Mei Tang, Serguei Soukharev, Masaomi Takizawa, Yohei Okada, Christine Fredericks, Derek Smith, Teresa Flegel, Tsubasa Watanabe, Sue Lee, Jason Luke
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2106887b43eca60a1596f5bb8ed43916
https://doi.org/10.1136/jitc-2022-sitc2022.0754
https://doi.org/10.1136/jitc-2022-sitc2022.0754
Autor:
Musashi Fukuda, Yoshiya Tanaka, Tsutomu Takeuchi, Mitsuhiro Rokuda, Yuichiro Kaneko, Daisuke Kato, Hiroyuki Izutsu
Publikováno v:
Modern Rheumatology. 32:708-717
Objective To analyse serious infection (SI) and herpes zoster-related disease (HZD) during long-term treatment of rheumatoid arthritis with the oral Janus kinase inhibitor, peficitinib (ASP015K). Methods This was a post hoc analysis of pooled data fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09b1ed44db1e2474294cd6cfc0990258
https://doi.org/10.1093/mr/roab069
https://doi.org/10.1093/mr/roab069
Autor:
Manish R. Patel, David J. Park, Stefano Tarantolo, Afshin Dowlati, Daniel Olson, Yuichiro Kaneko, Mei Tang, Serguei Soukharev, Masaomi Takizawa, Yohei Okada, Christine Fredericks, Teresa Flegel, Tsubasa Watanabe, Sue Lee, Jason John Luke
Publikováno v:
Cancer Research. 83:CT132-CT132
Background: Checkpoint inhibitors and have been transformative in the treatment practices of oncology. However, only a subset of all patients in most cancer types effectively respond to these therapies and acquired resistance is common, causing some
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0aba7dc932d325df7fc1083b5279a25
https://doi.org/10.1158/1538-7445.am2023-ct132
https://doi.org/10.1158/1538-7445.am2023-ct132